ECTRIMS 2016

September 15, 2016

A small molecule therapy for MS patients appears to override inhibitors of oligodendrogenesis to ind
Read More

ENDECE to Present Data at the 2016 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress

September 14, 2016

ENDECE will present “A small molecule therapy for MS patients appears to override inhibitors of ol
Read More

ENDECE Receives Additional U.S. Patent Covering NDC-1308 for Inducing Remyelination

July 12, 2016

Patent Strengthens ENDECE’s Intellectual Property and Clinical Development Programs for Potential
Read More

ENDECE Newsletter May 2016

June 1, 2016

NDC-1308 Timeline, Drug Approval Process. How close is NDC-1308 To The Clinic?
Read More

ENDECE to Present Data on NDC-1308, a Small Molecule with Remyelinating Activity for Treatment of Secondary Progressive Multiple Sclerosis

May 9, 2016

ENDECE will present “NDC-1308, a Small Molecule with Remyelinating Activity for Treatment of Secon
Read More

2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers

March 4, 2016

Endece Neural will be presenting at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis
Read More